Seagull BioSolutions is focused on development and commercialization of new technologies for healthcare applications. We have endogenously developed a mammalian expression system “The eSAME technology” that is useful for producing recombinant protein, viral vaccines, therapeutic and gene therapy agents. We are now using this versatile technology platform to develop new healthcare products that address important unmet medical needs.
The R&D team at Seagull consists of nationally & internationally trained scientists and works out of a facility located in the NCL Innovation park, Pune (INDIA) where we are a resident incubatee of Venture Center. The close proximity of leading research institutes like the National Chemical Laboratory, National Institute of Virology, Indian Institute of Scientific and Educational Research, National Center for Cell Sciences and Agarkar Research Institute allow for close interactions with leading academic researchers.